Pfizer-Connect Biopharma deal for anti-inflammatory agent ends Connect Biopharma (NASDAQ:CNTB) has decided to end a licensing deal with Pfizer (NYSE:PFE) for an oral anti-inflammatory agent named CBP-174 as part of its efforts to prioritize its lead asset ... 04/17/2024 - 7:27 am | View Link